{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:39:28Z","timestamp":1790203168207,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,11,25]],"date-time":"2014-11-25T00:00:00Z","timestamp":1416873600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s12149-014-0931-9","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T13:20:29Z","timestamp":1417440029000},"page":"224-232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Comparison of 11C-4\u2032-thiothymidine, 11C-methionine, and 18F-FDG PET\/CT for the detection of active lesions of multiple myeloma"],"prefix":"10.1007","volume":"29","author":[{"given":"Momoko","family":"Okasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryogo","family":"Minamimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyako","family":"Morooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiteru","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiichi","family":"Ishiwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Toyohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomio","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risen","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,25]]},"reference":[{"key":"931_CR1","unstructured":"Munshi NC, Anderson KC. Plasma cell neoplasms. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 2155\u201388."},{"key":"931_CR2","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(04)15736-X","volume":"363","author":"B Sirohi","year":"2004","unstructured":"Sirohi B, Powles R. Multiple myeloma. Lancet. 2004;363:875\u201387.","journal-title":"Lancet"},{"key":"931_CR3","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1001\/archinte.1996.00440120125014","volume":"156","author":"J Blade","year":"1996","unstructured":"Blade J, Kyle RA, Greipp PR. Multiple myeloma in patients younger than 30\u00a0years: report of 10 cases and review of the literature. Arch Intern Med. 1996;156:1463\u20138.","journal-title":"Arch Intern Med"},{"key":"931_CR4","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","volume":"351","author":"AR Kyle","year":"2004","unstructured":"Kyle AR, Rajkumar SV. Multiple myeloma. N Engl J Med. 2004;351:1860\u201373.","journal-title":"N Engl J Med"},{"key":"931_CR5","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364:1046\u201360. doi: 10.1056\/NEJMra1011442 .","journal-title":"N Engl J Med"},{"key":"931_CR6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMc1106428","volume":"365","author":"SV Rajkumar","year":"2011","unstructured":"Rajkumar SV, Larson D, Kyle RA. Diagnosis of smoldering multiple myeloma. N Engl J Med. 2011;365:474\u20135. doi: 10.1056\/NEJMc1106428 .","journal-title":"N Engl J Med"},{"key":"931_CR7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.ejca.2005.11.037","volume":"42","author":"BG Durie","year":"2006","unstructured":"Durie BG. The role of anatomic and functional staging in myeloma: description of Durie\/Salmon plus staging system. Eur J Cancer. 2006;42:1539\u201343.","journal-title":"Eur J Cancer"},{"key":"931_CR8","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1200\/JCO.2005.01.904","volume":"23","author":"ME Juweid","year":"2005","unstructured":"Juweid ME, Cheson BD. Role of positron emission tomography in lymphoma. J Clin Oncol. 2005;23:4577\u201380.","journal-title":"J Clin Oncol"},{"key":"931_CR9","first-page":"1356","volume":"46","author":"E Even-Sapir","year":"2005","unstructured":"Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic and hybrid modalities. J Nucl Med. 2005;46:1356\u201367.","journal-title":"J Nucl Med"},{"key":"931_CR10","first-page":"175803","volume":"2012","author":"C Caldarella","year":"2012","unstructured":"Caldarella C, Treglia G, Isgr\u00f2 MA, Treglia I, Giordano A. The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to treatment in patients with multiple myeloma. Int J Mol Imaging. 2012;2012:175803. doi: 10.1155\/2012\/175803 (Epub 2012 Aug 10).","journal-title":"Int J Mol Imaging."},{"key":"931_CR11","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2214\/ajr.184.4.01841199","volume":"184","author":"MA Bredella","year":"2005","unstructured":"Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R. Value of FDG PET in the assessment of patients with multiple myeloma. AJR Am J Roentgenol. 2005;184:1199\u2013204.","journal-title":"AJR Am J Roentgenol"},{"key":"931_CR12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00259-011-1993-8","volume":"39","author":"T Derlin","year":"2012","unstructured":"Derlin T, Weber C, Habermann CR, Herrmann J, Wisotzki C, Ayuk F, et al. 18F-FDG PET\/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation. Eur J Nucl Med Mol Imaging. 2012;39:493\u2013500.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"931_CR13","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1200\/JCO.2004.00.8581","volume":"23","author":"T Mahfouz","year":"2005","unstructured":"Mahfouz T, Miceli MH, Saghafifar F, Stroud S, Jones-Jackson L, Walker R, et al. 18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes. J Clin Oncol. 2005;23:7857\u201363.","journal-title":"J Clin Oncol"},{"key":"931_CR14","first-page":"2","volume":"14","author":"A Sood","year":"2011","unstructured":"Sood A, Revannasiddaiah S, Kumar R. Nuclear medicine in myeloma: the state of the science and emerging trends. Hell J Nucl Med. 2011;14:2\u20135.","journal-title":"Hell J Nucl Med."},{"key":"931_CR15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s12185-010-0595-8","volume":"91","author":"M Nishizawa","year":"2010","unstructured":"Nishizawa M, Nakamoto Y, Suga T, Kitano T, Ishikawa T, Yamashita K. 11C-Methionine PET\/CT for multiple myeloma. Int J Hematol. 2010;91:733\u20134.","journal-title":"Int J Hematol"},{"key":"931_CR16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1148\/radiol.2422051980","volume":"242","author":"A Dankerl","year":"2007","unstructured":"Dankerl A, Liebisch P, Glatting G, Friesen C, Blumstein NM, Kocot D, et al. Multiple myeloma: molecular imaging with 11C-methionine PET\/CT\u2014initial experience. Radiology. 2007;242:498\u2013508.","journal-title":"Radiology"},{"key":"931_CR17","first-page":"274","volume":"46","author":"M Muzi","year":"2005","unstructured":"Muzi M, Vesselle H, Grierson JR, Mankoff DA, Schmidt RA, Peterson L, et al. Kinetic analysis of 3\u2032-deoxy-3\u2032-fluorothymidine PET studies: validation studies in patients with lung cancer. J Nucl Med. 2005;46:274\u201386.","journal-title":"J Nucl Med"},{"key":"931_CR18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.nucmedbio.2007.10.001","volume":"35","author":"J Toyohara","year":"2008","unstructured":"Toyohara J, Okada M, Toramatsu C, Suzuki K, Irie T. Feasibility studies of 4\u2032-[methyl-11C]thiothymidine as a tumor proliferation imaging agent in mice. Nucl Med Biol. 2008;35:67\u201374.","journal-title":"Nucl Med Biol"},{"key":"931_CR19","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2967\/jnumed.111.088435","volume":"52","author":"J Toyohara","year":"2011","unstructured":"Toyohara J, Nariai T, Sakata M, Oda K, Ishii K, Kawabe T, et al. Whole-body distribution and brain tumor imaging with 11C-4DST: a pilot study. J Nucl Med. 2011;52:1322\u20138.","journal-title":"J Nucl Med"},{"key":"931_CR20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2967\/jnumed.111.095539","volume":"53","author":"R Minamimoto","year":"2012","unstructured":"Minamimoto R, Toyohara J, Seike A, Ito H, Endo H, Morooka M, et al. 4\u2032-[Methyl-11C]-thiothymidine PET\/CT for proliferation imaging in non-small cell lung cancer. J Nucl Med. 2012;53:199\u2013206.","journal-title":"J Nucl Med."},{"key":"931_CR21","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2967\/jnumed.108.061341","volume":"50","author":"M Morooka","year":"2009","unstructured":"Morooka M, Kubota K, Kadowaki H, Ito K, Okazaki O, Kashida M, et al. 11C-Methionine PET of acute myocardial Infarction. J Nucl Med. 2009;50:1283\u20137.","journal-title":"J Nucl Med"},{"key":"931_CR22","volume-title":"Positron emission tomography","author":"Dale L Bailey","year":"2006","unstructured":"Bailey Dale L, Townsend David W, Valk Peter E, Maisey Michael N. Positron emission tomography. London: Springer; 2006."},{"key":"931_CR23","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s00259-012-2333-3","volume":"40","author":"Y Nakamoto","year":"2013","unstructured":"Nakamoto Y, Kurihara K, Nishizawa M, Yamashita K, Nakatani K, Kondo T, et al. Clinical value of 11C-methionine PET\/CT in patients with plasma cell malignancy: comparison with 18F-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2013;40:708\u201315.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"931_CR24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working Group","year":"2003","unstructured":"International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749\u201357.","journal-title":"Br J Haematol"},{"key":"931_CR25","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/leu.2009.89","volume":"23","author":"M Dimopoulos","year":"2009","unstructured":"Dimopoulos M, Terpos E, Comenzo RL, Tosi P, Beksac M, Sezer O, et al. IMWG. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma. Leukemia. 2009;23:1545\u201356.","journal-title":"Leukemia"},{"key":"931_CR26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/108497803770418382","volume":"18","author":"H Schirrmeister","year":"2003","unstructured":"Schirrmeister H, Buck AK, Bergmann L, Reske SN, Bommer M. Positron emission tomography (PET) for staging of solitary plasmacytoma. Cancer Biother Radiopharm. 2003;18:841\u20135.","journal-title":"Cancer Biother Radiopharm."},{"key":"931_CR27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2967\/jnumed.111.098830","volume":"53","author":"RC Walker","year":"2012","unstructured":"Walker RC, Brown TL, Jones-Jackson LB, De Blanche L, Bartel T. Imaging of multiple myeloma and related plasma cell dyscrasias. J Nucl Med. 2012;53:1091\u2013101.","journal-title":"J Nucl Med"},{"key":"931_CR28","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346:564\u20139.","journal-title":"N Engl J Med"},{"key":"931_CR29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78:21\u201333.","journal-title":"Mayo Clin Proc"},{"key":"931_CR30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1148\/radiographics.19.1.g99ja0761","volume":"19","author":"PD Shreve","year":"1999","unstructured":"Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19:61\u201377.","journal-title":"Radiographics."}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-014-0931-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-014-0931-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-014-0931-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:16:25Z","timestamp":1553627785000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-014-0931-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,25]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["931"],"URL":"https:\/\/doi.org\/10.1007\/s12149-014-0931-9","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,25]]}}}